Acute liver failure following immune checkpoint inhibitors

Haanen, 2017, Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol Off J Eur Soc Med Oncol, 28 Rousseau, 2023, Anti-TIGIT therapies for solid tumors: a systematic review, ESMO Open, 8 De Martin, 2018, Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors, J Hepatol, 68, 1181, 10.1016/j.jhep.2018.01.033 Bhave, 2018, Mortality due to immunotherapy related hepatitis, J Hepatol, 69, 976, 10.1016/j.jhep.2018.06.012 Riveiro-Barciela, 2019, Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: new settings call for new treatment strategies?, J Hepatol, 70, 564, 10.1016/j.jhep.2018.10.020 Reeves, 2014, The mechanisms of action of plasma exchange, Br J Haematol, 164, 342, 10.1111/bjh.12629 Larsen, 2016, High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial, J Hepatol, 64, 69, 10.1016/j.jhep.2015.08.018